Short Takes
Video Interviews With Industry Leaders
The Digital Health Coalition partners with a wide array of pharmaceutical industry leaders and key stakeholders to facilitate and disseminate insights on a range of topics related to digital pharmaceutical marketing innovation.
Short Takes Archive
CEO, HealthLink Dimensions
In this Short Take interview, Mark Bard speaks with Amar Duggasani, CEO of HealthLink Dimensions, about current innovations in healthcare data management and the impact of leveraging advanced technology to realize enhancing communication between healthcare organizations and professionals. Duggasani shares insights into the future of healthcare data solutions and the importance of data accuracy in improving patient care.
Check out HealthLink Dimensions’ 2024 NPs and PAs Communications Report HERE
Global Digital Health and Innovation Lead, Sanofi
Mark Bard, with DHC Group, and Nandini Nayar, Global Digital Health and Innovation Lead, Sanofi, discussed the evolution of patient-centricity, patient experience, and overall digital health trends in the pharmaceutical industry. The conversation also discussed challenges in the clinical trial processes and the potential for innovation in patient access for specialty medications. They also explored the potential for pharmaceutical companies to fund the creation of models and care pathways to improve patient diagnosis and control, and the importance of integrating these tools into physicians’ workflows.
Health Experience Officer, Otsuka Precision Health
Mark Bard, DHC Group, and Desiree Priestley, Otsuka Precision Health, discussed Desiree’s experiences on the commercial side of pharma and the challenges and opportunities in the current and future generations of patient support and customer experience programs. They also explored the evolution of patient experience and support in the pharmaceutical industry, the growth of digital therapeutics, and the importance of direct-to-patient (DTP) and customer experience overall.
#GenAI4Pharma
Health IT CEO and Entrepreneur
Mark Bard, DHC Group, and Yin Ho, MD discussed the emergence, evolution, and future of AI in the delivery of medicine and clinical decision making. Yin also discusses her upcoming book about the history of health information technology and its implications for AI. Topics covered include the potential of AI to revolutionize healthcare, with a deep dive on the integration into Electronic Medical Records (EMRs) and the challenges and solutions for this deep integration. Lastly, they discussed the involvement of physicians in the development and implementation of AI in medicine, the challenges of entrepreneurship, and the integration of AI in the pharmaceutical industry.
Regulatory Expert, Former Sanofi
Mark Bard spoke with Mark Gaydos, former Sanofi, about the the latest trends in regulatory, promotion, and digital. The conversation begins with a review of trends for the year ahead – including genAI – as well as a review of the challenges and opportunities with dynamic and modular content for customers. They close the session out with a review of how regulatory thinks about HCP Social Influencers and how to successfully structure those relationships with KOLs and brands.
Chief Revenue Officer, DrFirst
Mark Bard spoke with Andrew Burns, DrFirst, about the challenges with medication adherence and the potential of technology to connect disparate parts of the system to ease the friction and pain points for patients. The discussion also touched on how to facilitate collaboration throughout the system to drive and optimize compliance and adherence overall.
Sermo Medical Advisory Board, Neurologist, and Director of Clinical Research at Community Neuroscience Services
Dr. Shivang Joshi joins Mark Bard of DHC at Sermo, a social network platform for physicians that allows members to connect with other physicians, earn money for their insights, solve challenging patient cases, and contribute to the world’s largest database of drug ratings.
In this conversation, Mark and Dr. Joshi discuss the challenges and potential solutions for pharmaceutical companies working with physician influencers. Dr. Joshi emphasizes the importance of authenticity and credibility in these relationships. They suggest focusing on general discussions about the disease state and products, rather than directly pitching specific products.